论文部分内容阅读
目的探讨心力衰竭合并心律失常患者的临床治疗方法和效果。方法从2013年1月-2015年4月济源市人民医院收治的心力衰竭合并心律失常患者中选出110例,将其分为两组,每组55例。对照组患者采取常规治疗措施;观察组患者则在常规治疗基础上应用胺碘酮联合稳心颗粒疗法。分别记录两组患者治疗效果和治疗前后心脏指标数据变化情况。结果观察组患者治疗总有效率为96.36%(53/55),明显高于对照组的81.82%(45/55)。两组患者治疗前心脏指标数据没有较大差异,治疗结束后观察组静息心率下降趋势明显优于对照组,而QT间期时间和左心室射血分数观察组上升趋势明显优于对照组,差异均有统计学意义(P<0.05)。结论在治疗心力衰竭合并心律失常患者时不能单纯采用常规治疗,还应该同时开展胺碘酮联合稳心颗粒治疗方法,能够提升治疗效果,改善患者心脏功能。
Objective To investigate the clinical treatment of patients with heart failure and arrhythmia. Methods From January 2013 to April 2015, 110 patients with heart failure and arrhythmia admitted to Jiyuan People’s Hospital were divided into two groups (55 in each group). Patients in the control group received routine treatment; patients in the observation group were treated with amiodarone combined with Wenxin Granule on the basis of routine treatment. The therapeutic effects of two groups of patients were recorded and the changes of cardiac index data before and after treatment were recorded. Results The total effective rate of observation group was 96.36% (53/55), which was significantly higher than that of the control group (81.82%, 45/55). There was no significant difference in cardiac index data between the two groups before treatment. After treatment, the decline tendency of resting heart rate in the observation group was better than that in the control group, while the QT interval time and left ventricular ejection fraction increased more obviously in the observation group than in the control group. The differences were statistically significant (P <0.05). Conclusion In the treatment of heart failure patients with arrhythmia can not simply use conventional therapy, but also should carry out amiodarone combined with Wenxin particles treatment method, can improve the therapeutic effect and improve cardiac function in patients.